We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 57 results
  1. Analysis of urinary C–C motif chemokine ligand 14 (CCL14) and first-generation urinary biomarkers for predicting renal recovery from acute kidney injury: a prospective exploratory study

    Background

    Acute kidney injury (AKI) is a frequent syndrome in the intensive care unit (ICU). AKI patients with kidney function recovery have better...

    Ben-Shu Qian, Hui-Miao Jia, ... Wen-**ong Li in Journal of Intensive Care
    Article Open access 20 March 2023
  2. Performance of urinary C–C motif chemokine ligand 14 for the prediction of persistent acute kidney injury: a systematic review and meta-analysis

    Background

    Urinary C–C motif chemokine ligand 14 (CCL14) has been described as an effective marker for delayed recovery of acute kidney injury (AKI),...

    Yih‑Ting Chen, Heng-Chih Pan, ... Eric Hoste in Critical Care
    Article Open access 18 August 2023
  3. Predictability performance of urinary C–C motif chemokine ligand 14 and renal resistive index for persistent sepsis-associated acute kidney injury in ICU patients

    Objectives

    The performance of renal resistance index (RRI) in predicting persistent sepsis-associated acute kidney injury (S-AKI) remains debatable,...

    Wei Jiang, Ting Liao, ... Ruiqiang Zheng in International Urology and Nephrology
    Article Open access 17 February 2023
  4. External validation of urinary C–C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury

    Background

    Persistent acute kidney injury (AKI) portends worse clinical outcomes and remains a therapeutic challenge for clinicians. A recent study...

    Sean M. Bagshaw, Ali Al-Khafaji, ... John A. Kellum in Critical Care
    Article Open access 31 May 2021
  5. Predictive performance of two types of urinary biomarkers for renal non-recovery in sepsis-associated acute kidney injury: a prospective observational study

    Background and purpose

    Renal non-recovery is known to have negative prognostic implications in patients suffering from acute kidney injury (AKI)....

    Licheng, Huimiao Jia, ... Wenxiong Li in BMC Nephrology
    Article Open access 03 May 2024
  6. Identification of key genes of anti-programmed death ligand 1 for meningioma immunotherapy by bioinformatic analysis

    Meningioma is one of the most common primary tumors in the central nervous system (CNS). A deeper understanding of its molecular characterization...

    Lijian Zhang, Luxuan Wang, ... Chuan Fang in Medical Oncology
    Article Open access 20 December 2022
  7. Comprehensive analysis of a chemokine- and chemokine receptor family-based signature for patients with lung adenocarcinoma

    The clinical significance and comprehensive features of chemokines and their receptors in lung adenocarcinoma (LUAD) have not been clarified. We...

    Tao Fan, Yu Liu, ... Jie He in Cancer Immunology, Immunotherapy
    Article 11 May 2021
  8. CC chemokines and receptors in osteoarthritis: new insights and potential targets

    Osteoarthritis (OA) is a prevalent degenerative disease accompanied by the activation of innate and adaptive immune systems-associated inflammatory...

    Yuchen Zhang, Di Liu, ... Yusheng Li in Arthritis Research & Therapy
    Article Open access 03 July 2023
  9. The kidney, COVID-19, and the chemokine network: an intriguing trio

    On December 30th 2019, some patients with pneumonia of unknown etiology were reported in the Program for Monitoring Emerging Diseases (ProMED), a...

    Gianluigi Taverna, Simona Di Francesco, ... Fabio Grizzi in International Urology and Nephrology
    Article 27 July 2020
  10. Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study

    Purpose

    The aim of the RUBY study was to evaluate novel candidate biomarkers to enable prediction of persistence of renal dysfunction as well as...

    Eric Hoste, Azra Bihorac, ... Lakhmir S. Chawla in Intensive Care Medicine
    Article Open access 06 February 2020
  11. CircTMC5 promotes gastric cancer progression and metastasis by targeting miR-361-3p/RABL6

    Background

    Gastric cancer (GC) is common in East Asia, yet its molecular and pathogenic mechanisms remain unclear. Circular RNAs (circRNAs) are...

    Peng Xu, **aoLan Xu, ... AMan Xu in Gastric Cancer
    Article 22 July 2021
  12. Different roles of protein biomarkers predicting eGFR trajectories in people with chronic kidney disease and diabetes mellitus: a nationwide retrospective cohort study

    Background

    Chronic kidney disease (CKD) is a common comorbidity in people with diabetes mellitus, and a key risk factor for further life-threatening...

    Michael Kammer, Andreas Heinzel, ... Rainer Oberbauer in Cardiovascular Diabetology
    Article Open access 29 March 2023
  13. Role of platelet to albumin ratio for predicting persistent acute kidney injury in patients admitted to the intensive care unit

    Background

    The aim of this study was to investigate the prognostic role of platelet to albumin ratio (PAR) and in persistent acute kidney injury...

    Yuanwei Zhai, **aoqiang Liu, ... Tianyang Hu in BMC Anesthesiology
    Article Open access 19 July 2023
  14. Neueste Entwicklungen bei der akuten Nierenschädigung

    Acute kidney injury (AKI) is a common problem in critically ill patients and is associated with increased morbidity and mortality. Since 2012, AKI...

    Timo Mayerhöfer, Fabian Perschinka, Michael Joannidis in Medizinische Klinik - Intensivmedizin und Notfallmedizin
    Article Open access 29 April 2024
  15. New diagnostics for AKI in critically ill patients: what to expect in the future

    Greet De Vlieger, Lui Forni, Antoine Schneider in Intensive Care Medicine
    Article 16 August 2022
  16. Delivering optimal renal replacement therapy to critically ill patients with acute kidney injury

    Critical illness is often complicated by acute kidney injury (AKI). In patients with severe AKI, renal replacement therapy (RRT) is deployed to...

    Ron Wald, William Beaubien-Souligny, ... Sean M. Bagshaw in Intensive Care Medicine
    Article 06 September 2022
  17. Fokus Nephrologie

    C. Nusshag, C. J. Reuß, ... T. Brenner in Der Anaesthesist
    Article 25 October 2020
  18. High Level of Ubiquitin Conjugate Enzyme E2O Indicates Poor Prognosis of Patients with Hepatocellular Carcinoma

    Objective

    Ubiquitin conjugate enzyme E2O (UBE2O) is a ubiquitin-conjugating enzyme that has been reported to be involved in tumorigenesis. This study...

    Si-yu Lan, Yang Ding, ... Ying Chang in Current Medical Science
    Article 21 October 2022
  19. Proenkephalin A 119–159 predicts early and successful liberation from renal replacement therapy in critically ill patients with acute kidney injury: a post hoc analysis of the ELAIN trial

    Background

    Renal replacement therapy (RRT) remains the key rescue therapy for critically ill patients with severe acute kidney injury (AKI). However,...

    Thilo von Groote, Felix Albert, ... Alexander Zarbock in Critical Care
    Article Open access 31 October 2022
Did you find what you were looking for? Share feedback.